Paul Olson

Paul K Olson


I am the President and co-founder of Kypha, a company dedicated to the diagnosis, treatment and monitoring of inflammatory disease. Lupus, severe trauma, and stroke are our lead indications. I am also a co-founder and former Chief Scientific Officer of Potentia Pharmaceuticals, the first company to enter clinical trials with a complement inhibitor for the treatment of age-related macular degeneration,

Biotechnology Genetics Immunology Ophthalmology Pharmacology Radiology & Medical Imaging Rheumatology

Institution affiliations

Work details


Kypha, Inc

Saint Louis University